The intracellular domain of FGFR3 was found to be a target of IgG antibodies in a subgroup of patients with sensory neuropathy, particularly in idiopathic or autoimmune-related cases [7]. This evidence concerns the gene FGFR3 and sensory peripheral neuropathy.